Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
All cancers have different mutations. Genomic testing can use these differences to predict how aggressively a cancer may behave and whether or not it’s likely to recur. Most frequently used for breast and prostate cancer, prognostic tumor tests helps doctors and patients decide how to treat a cancer. Insurance often covers the cost of these tests, especially those that are included in the National Comprehensive Cancer Network (NCCN) Guidelines.
Some examples of the most commonly used prognostic tests for breast cancer are:
NCCN Guidelines for prostate cancer include discussion of several different tests that can predict the aggressiveness and risk for recurrence of a tumor. More aggressive treatment may be offered to men with an aggressive cancer and a higher likelihood of recurrence. These tests include: